However, some transporters, including OATP1B1/3 and OAT3, demonstrated inhibition following treatment with GLP-1 RAs and a dual GLP-1/GIP RA in vitro, suggesting that the assessment of transporter-mediated DDI by GLP-1 RAs may be necessary (Table 3)
Refrigeration not necessary Research Grade: For laboratory research purposes only
The research is promising, but it remains too early to describe MOTS-c as a proven human weight-loss treatment
A study of nearly 28,000 23andMe users who reported taking GLP-1 weight-loss medications, published in Nature, found that a mutation in GLP1R, the gene encoding the protein targeted by GLP-1 drugs, was modestly but significantly associated with greater weight loss
There is a tremendous need for medical therapies that could reach high numbers of obese patients
Systemic inflammatory signals can easily cross the BBB to enhance neuroinflammatory responses and promote acceleration in AD pathology (Xie et al., 2022)